http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2737503-C9
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc8e1fce359ef4ee5bdc0add916dc5bd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2020-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccf2631d164a6fc51f914c7a0b063e39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a19804c2a0764704c6662c8e1cb35066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfb9a60e70ab8d353c80c15a6f7c319e |
| publicationDate | 2021-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2737503-C9 |
| titleOfInvention | Method of personified prediction of clinical effectiveness of non-alcoholic fatty liver disease in patients with metabolic syndrome |
| abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to internal diseases, and can be used to select personified prediction of clinical effectiveness of non-alcoholic fatty liver disease in patients with metabolic syndrome. Method of personified prediction of clinical effectiveness of non-alcoholic fatty liver disease in patients with ursodeoxycholic acid syndrome in a daily dosage of 15 mg per kg of body weight divided into 3 doses (after breakfast, after lunch and after dinner) in combination with Rosuvastatin 10 mg a day (after dinner) within 6 months includes determining initial values of alanine aminotransferase (ALT, units/l); level of C-reactive protein (CRP, mg/l); atherogenic index (AI) level; insulin resistance index (IR) level; level of diastolic arterial pressure (APd, mm Hg) and solving the discriminant equation: D=0.157×ALT+0.127×CRP+0.286×AI+0.515×IR+0.034×APd-10.948, where D is a discriminant function with its boundary value equal to zero, wherein if D is less than or equal to zero, a positive clinical outcome is predicted, and if D is greater than zero, a negative clinical outcome is predicted.EFFECT: invention provides higher accuracy of personalized prediction of clinical effectiveness of non-alcoholic fatty liver disease.1 cl, 2 ex |
| priorityDate | 2020-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 121.